# Inclusion of Older Adults in Cancer Clinical Trials:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/inclusion-of-older-adults-in-cancer-clinical-trials-guidance-for-industry/58e758a2-a626-41ba-8346-44066b8cd50f

> FDA guidance document: Inclusion of Older Adults in Cancer Clinical Trials:  Guidance for Industry. Issue date: March 02, 2022. Get complete insights and analysis.

---

## Details

- Title: Inclusion of Older Adults in Cancer Clinical Trials:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2022-03-02
- Last Changed: 2022-03-02
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2019-D-5572">FDA-2019-D-5572</a>

## Related Documents

- [Cancer Clinical Trial Eligibility Criteria: Available Therapy in Non-Curative Settings:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-available-therapy-in-non-curative-settings-guidance-for-industry/d21a3c21-c758-4f3f-b215-edfe13aa09a3)
- [Cross Labeling Oncology Drugs in Combination Regimens](https://www.globalkeysolutions.net/guidances/guidance-document/cross-labeling-oncology-drugs-in-combination-regimens/d50f604f-4d0f-4aaa-a83a-b8a75b4a71ee)
- [Cancer Clinical Trial Eligibility Criteria: Brain Metastases](https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-brain-metastases/18dfb9e1-7a58-4743-8321-ecddace907a4)